Correction to: BJC Reports 10.1038/s44276-026-00228-8, published online 08 May 2026
In this article, the author name ‘Gerusa Duarte Dalmolin’ has been erroneously published as ‘Duarte Gerusa Dalmolin’.
The original article has been corrected.
. 2026 Jun 24;4:35. doi: 10.1038/s44276-026-00236-8
Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide
Silvia Rancati
1, Matilde Campolungo
1,2, Gerusa Duarte Dalmolin
1, Pierre Lau
3, Federica Furia
4, Alessandro Coppe
4, Fabio Landuzzi
4, Manuela Vecchi
5, Andrea Cavalli
4,6,7, Stefano Gustincich
3,5, Nicola Tirelli
1,✉
Silvia Rancati
1Center for Convergent Technologies, Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
Find articles by Silvia Rancati
Matilde Campolungo
1Center for Convergent Technologies, Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
2Open University Affiliated Research Centre at Istituto Italiano di Tecnologia (ARC@IIT), Genova, Italy
Find articles by Matilde Campolungo
Gerusa Duarte Dalmolin
1Center for Convergent Technologies, Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
Find articles by Gerusa Duarte Dalmolin
Pierre Lau
3Center for Human Technologies, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
Find articles by Pierre Lau
Federica Furia
4Center for Clinical and Computational Genomics, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
Find articles by Federica Furia
Alessandro Coppe
4Center for Clinical and Computational Genomics, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
Find articles by Alessandro Coppe
Fabio Landuzzi
4Center for Clinical and Computational Genomics, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
Find articles by Fabio Landuzzi
Manuela Vecchi
5Center for Clinical and Computational Genomics, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
Find articles by Manuela Vecchi
Andrea Cavalli
4Center for Clinical and Computational Genomics, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
6Center for Human Technologies, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Genvoa, Italy
7Centre Européen de Calcul Atomique et Moléculaire (CECAM), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Find articles by Andrea Cavalli
Stefano Gustincich
3Center for Human Technologies, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
5Center for Clinical and Computational Genomics, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
Find articles by Stefano Gustincich
Nicola Tirelli
1Center for Convergent Technologies, Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
Find articles by Nicola Tirelli
1Center for Convergent Technologies, Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
2Open University Affiliated Research Centre at Istituto Italiano di Tecnologia (ARC@IIT), Genova, Italy
3Center for Human Technologies, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Genova, Italy
4Center for Clinical and Computational Genomics, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
5Center for Clinical and Computational Genomics, Non-coding RNAs and RNA-based therapeutics, Fondazione Istituto Italiano di Tecnologia (IIT), Aosta, Italy
6Center for Human Technologies, Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia (IIT), Genvoa, Italy
7Centre Européen de Calcul Atomique et Moléculaire (CECAM), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
✉
Corresponding author.
Collection date 2026.
© The Author(s) 2026
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
PMCID: PMC13291256 PMID: 42337329
This corrects the article "Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide", 24.